KEGG   Acinonyx jubatus (cheetah): 106979326
Entry
106979326         CDS       T04657                                 
Name
(RefSeq) caspase-3 isoform X3
  KO
K02187  caspase 3 [EC:3.4.22.56]
Organism
aju  Acinonyx jubatus (cheetah)
Pathway
aju01524  Platinum drug resistance
aju04010  MAPK signaling pathway
aju04115  p53 signaling pathway
aju04148  Efferocytosis
aju04210  Apoptosis
aju04215  Apoptosis - multiple species
aju04623  Cytosolic DNA-sensing pathway
aju04650  Natural killer cell mediated cytotoxicity
aju04657  IL-17 signaling pathway
aju04668  TNF signaling pathway
aju04726  Serotonergic synapse
aju04932  Non-alcoholic fatty liver disease
aju04933  AGE-RAGE signaling pathway in diabetic complications
aju04936  Alcoholic liver disease
aju05010  Alzheimer disease
aju05012  Parkinson disease
aju05014  Amyotrophic lateral sclerosis
aju05016  Huntington disease
aju05020  Prion disease
aju05022  Pathways of neurodegeneration - multiple diseases
aju05132  Salmonella infection
aju05133  Pertussis
aju05134  Legionellosis
aju05145  Toxoplasmosis
aju05146  Amoebiasis
aju05152  Tuberculosis
aju05160  Hepatitis C
aju05161  Hepatitis B
aju05162  Measles
aju05163  Human cytomegalovirus infection
aju05164  Influenza A
aju05165  Human papillomavirus infection
aju05167  Kaposi sarcoma-associated herpesvirus infection
aju05168  Herpes simplex virus 1 infection
aju05169  Epstein-Barr virus infection
aju05170  Human immunodeficiency virus 1 infection
aju05200  Pathways in cancer
aju05203  Viral carcinogenesis
aju05205  Proteoglycans in cancer
aju05206  MicroRNAs in cancer
aju05210  Colorectal cancer
aju05222  Small cell lung cancer
aju05416  Viral myocarditis
aju05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:aju00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    106979326
   04668 TNF signaling pathway
    106979326
 09140 Cellular Processes
  09141 Transport and catabolism
   04148 Efferocytosis
    106979326
  09143 Cell growth and death
   04210 Apoptosis
    106979326
   04215 Apoptosis - multiple species
    106979326
   04115 p53 signaling pathway
    106979326
 09150 Organismal Systems
  09151 Immune system
   04623 Cytosolic DNA-sensing pathway
    106979326
   04650 Natural killer cell mediated cytotoxicity
    106979326
   04657 IL-17 signaling pathway
    106979326
  09156 Nervous system
   04726 Serotonergic synapse
    106979326
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    106979326
   05206 MicroRNAs in cancer
    106979326
   05205 Proteoglycans in cancer
    106979326
   05203 Viral carcinogenesis
    106979326
  09162 Cancer: specific types
   05210 Colorectal cancer
    106979326
   05222 Small cell lung cancer
    106979326
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    106979326
   05161 Hepatitis B
    106979326
   05160 Hepatitis C
    106979326
   05164 Influenza A
    106979326
   05162 Measles
    106979326
   05168 Herpes simplex virus 1 infection
    106979326
   05163 Human cytomegalovirus infection
    106979326
   05167 Kaposi sarcoma-associated herpesvirus infection
    106979326
   05169 Epstein-Barr virus infection
    106979326
   05165 Human papillomavirus infection
    106979326
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    106979326
   05133 Pertussis
    106979326
   05134 Legionellosis
    106979326
   05152 Tuberculosis
    106979326
  09174 Infectious disease: parasitic
   05146 Amoebiasis
    106979326
   05145 Toxoplasmosis
    106979326
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    106979326
   05012 Parkinson disease
    106979326
   05014 Amyotrophic lateral sclerosis
    106979326
   05016 Huntington disease
    106979326
   05020 Prion disease
    106979326
   05022 Pathways of neurodegeneration - multiple diseases
    106979326
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    106979326
   05416 Viral myocarditis
    106979326
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    106979326
   04932 Non-alcoholic fatty liver disease
    106979326
   04933 AGE-RAGE signaling pathway in diabetic complications
    106979326
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    106979326
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01002 Peptidases and inhibitors [BR:aju01002]
    106979326
Enzymes [BR:aju01000]
 3. Hydrolases
  3.4  Acting on peptide bonds (peptidases)
   3.4.22  Cysteine endopeptidases
    3.4.22.56  caspase-3
     106979326
Peptidases and inhibitors [BR:aju01002]
 Cysteine peptidases
  Family C14: caspase family
   106979326
SSDB
Motif
Pfam: Peptidase_C14
Other DBs
NCBI-GeneID: 106979326
NCBI-ProteinID: XP_026932905
UniProt: A0A6J2AXC1
LinkDB
Position
B1:complement(14924844..14948326)
AA seq 278 aa
MENSENSVDAKSIKNSETRKIFHGSKSMDSGIYMDNSYKMDYPEMGLCIIINNKNFHEST
GMPSRSGTDVDAANLRETFTNLKYEVRNKNDLTREQIVALLDSVSREDHSKRSSFICVLL
SHGDEGIIYGTNGPVDLKKLTGFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGTE
DDIACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCSMLRLYAHKLEFMHILTRV
NRKVALEFESFSLDSAFHGKKQIPCIVSMLTKELYFYH
NT seq 837 nt   +upstreamnt  +downstreamnt
atggagaacagtgaaaactcagtggatgcaaaatccattaaaaattccgaaaccagaaag
atcttccatggaagcaaatcaatggactctggaatatacatggacaacagttacaaaatg
gattaccctgaaatgggtttatgtataataattaataataagaactttcatgaaagtacc
ggaatgccatctcggtctggtacagatgtggatgcggcgaacctccgagaaacattcaca
aacttgaaatacgaagtcaggaataaaaacgatcttacacgcgaacaaattgtggcgttg
ctggacagtgtttctagagaagatcatagcaaaaggagcagttttatttgtgtgcttcta
agccacggtgatgaaggaatcatttatggaacaaacggacctgttgacctgaaaaaatta
acaggtttcttcagaggggattattgtagaagtctaaccggcaaacccaaactcttcatt
attcaggcctgccgaggcacggaactcgactgcggcattgagactgacagtggtaccgag
gatgacatcgcctgtcagaaaataccagtggaagccgacttcttatatgcgtattccaca
gcccctggttactactcctggcgaaactccaaggatggatcctggttcatccagtcactt
tgctcgatgctcagactgtatgctcacaagcttgagttcatgcacattcttactcgggtt
aaccgaaaggtagctctagaatttgagtccttttctcttgactctgcttttcatggaaag
aaacagattccatgtattgtgtctatgctcacaaaagaactatatttttatcactaa

DBGET integrated database retrieval system